Walgreens plays down Amazon pharmacy entry, but investors spooked
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall St tumbles on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil drops $1 as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Guggenheim Remains Bullish on Amazon (AMZN) Following PillPack Acquisition
July 2, 2018 7:37 AM EDTGuggenheim reiterated a Buy rating and $1850.00 price target on Amazon.com (NASDAQ: AMZN) following the company's recent acquisition of PillPack. This drove a 5-10% correction in drug retail shares on the assumption that this would place incremental pressure on pricing and profitability.
Analyst John... More
Walgreens Boosts Alliance (WBA) PT Lowered to $68 at RBC Capital
June 29, 2018 8:02 AM EDTRBC Capital lowered its price target on Walgreens Boosts Alliance (NASDAQ: WBA) to $68.00 (from $88.00) while maintaining an Outperform rating.
Analyst George Hill views the sharp downward move Thursday following Amazon's entry into the pharmacy space as an overreaction.
... MoreCVS Health (CVS) PT Lowered to $84 at RBC Capital on Amazon Effect
June 29, 2018 7:10 AM EDTRBC Capital lowered its price target on CVS Health (NYSE: CVS) to $84.00 (from $91.00) while maintaining an Outperform rating to reflect Amazon's entrance into the pharmacy space.
"We acknowledge that Amazon has disrupted industries in the past, but believe that the stickiness of payer/ pharmacy... More
Walgreens Boosts Alliance (WBA) PT Lowered to $64 at Evercore ISI; Today was a 'Complete Mess', But Maintaining OP Rating
June 28, 2018 11:51 AM EDTEvercore ISI lowered its price target on Walgreens Boosts Alliance (NASDAQ: WBA) to $64.00 (from $74.00) while maintaining an Outperform rating.
Analyst Ross Muken commented, "What a complete mess today turned out to be (and here I was worried about balancing MCKs Analyst Day w/ WBAs report). While on the surface WBAs print... More
